Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reaching the Last 20%: a Targeted HIV Self-test Secondary Distribution Intervention to Engage High-risk Men in Kenya

NCT05882916 is registered in ClinicalTrials.gov with Sue Napierala as lead sponsor.

NCT NCT05882916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05882916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reaching the Last 20%: a Targeted HIV Self-test Secondary Distribution Intervention to Engage High-risk Men in Kenya
Lead sponsor
Sue Napierala
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2024
Completion date
August 7, 2026
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv